Roderick Tang
Affiliations: | Meissa Vaccines inc |
Area:
VaccinesGoogle:
"Roderick Tang"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| David E. Draper | grad student | Johns Hopkins | |
| Karla Kirkegaard | grad student | Stanford University Medical School (Microtree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tioni MF, Jordan R, Pena AS, et al. (2022) Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2. Npj Vaccines. 7: 85 |
| Lambert SL, Aslam S, Stillman E, et al. (2015) A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models. Plos One. 10: e0119509 |
| Malkin E, Yogev R, Abughali N, et al. (2013) Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age. Plos One. 8: e77104 |
| Lawlor HA, Schickli JH, Tang RS. (2013) A single amino acid in the F2 subunit of respiratory syncytial virus fusion protein alters growth and fusogenicity. The Journal of General Virology. 94: 2627-35 |
| Kurzweil V, Tang R, Galinski M, et al. (2013) Translational sciences approach to RSV vaccine development. Expert Review of Vaccines. 12: 1047-60 |
| Yang CF, Wang CK, Malkin E, et al. (2013) Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine. Vaccine. 31: 2822-7 |
| Schickli JH, Kaur J, Tang RS. (2012) Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030ΔSH) at permissive and non-permissive temperatures. Virus Research. 169: 38-47 |
| Schickli JH, Dubovsky F, Tang RS. (2009) Challenges in developing a pediatric RSV vaccine. Human Vaccines. 5: 582-91 |
| Tang RS, Mahmood K, Macphail M, et al. (2005) A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine. 23: 1657-67 |
| Tang RS, MacPhail M, Schickli JH, et al. (2004) Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys. Journal of Virology. 78: 11198-207 |